Annual Cash & Cash Equivalents
$11.52 M
-$20.67 M-64.20%
December 31, 2023
Summary
- As of February 28, 2025, MTEM annual cash & cash equivalents is $11.52 million, with the most recent change of -$20.67 million (-64.20%) on December 31, 2023.
- During the last 3 years, MTEM annual cash & cash equivalents has fallen by -$13.70 million (-54.31%).
- MTEM annual cash & cash equivalents is now -86.86% below its all-time high of $87.72 million, reached on December 31, 2018.
Performance
MTEM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$9.66 M
+$2.88 M+42.45%
June 30, 2024
Summary
- As of February 28, 2025, MTEM quarterly cash and cash equivalents is $9.66 million, with the most recent change of +$2.88 million (+42.45%) on June 30, 2024.
- Over the past year, MTEM quarterly cash and cash equivalents has increased by +$2.88 million (+42.45%).
- MTEM quarterly cash and cash equivalents is now -90.22% below its all-time high of $98.79 million, reached on March 31, 2021.
Performance
MTEM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MTEM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -64.2% | +42.5% |
| 3 y3 years | -54.3% | -75.1% |
| 5 y5 years | -86.9% | -75.1% |
MTEM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.2% | at low | -75.1% | +95.0% |
| 5 y | 5-year | -86.5% | at low | -90.2% | +95.0% |
| alltime | all time | -86.9% | +95.9% | -90.2% | +159.0% |
Molecular Templates Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $9.66 M(+42.5%) |
| Mar 2024 | - | $6.78 M(-41.2%) |
| Dec 2023 | $11.52 M(-64.2%) | $11.52 M(-27.1%) |
| Sep 2023 | - | $15.81 M(+219.3%) |
| Jun 2023 | - | $4.95 M(-87.2%) |
| Mar 2023 | - | $38.78 M(+20.5%) |
| Dec 2022 | $32.19 M(+28.8%) | $32.19 M(+44.5%) |
| Sep 2022 | - | $22.28 M(-17.3%) |
| Jun 2022 | - | $26.94 M(+37.6%) |
| Mar 2022 | - | $19.57 M(-21.7%) |
| Dec 2021 | $24.98 M(-0.9%) | $24.98 M(-9.5%) |
| Sep 2021 | - | $27.59 M(-36.0%) |
| Jun 2021 | - | $43.09 M(-56.4%) |
| Mar 2021 | - | $98.79 M(+291.7%) |
| Dec 2020 | $25.22 M(-70.5%) | $25.22 M(-24.5%) |
| Sep 2020 | - | $33.41 M(+20.9%) |
| Jun 2020 | - | $27.64 M(-19.7%) |
| Mar 2020 | - | $34.44 M(-59.7%) |
| Dec 2019 | $85.45 M(-2.6%) | $85.45 M(+459.7%) |
| Sep 2019 | - | $15.27 M(-9.1%) |
| Jun 2019 | - | $16.80 M(-55.6%) |
| Mar 2019 | - | $37.85 M(-56.8%) |
| Dec 2018 | $87.72 M(+48.9%) | $87.72 M(+11.4%) |
| Sep 2018 | - | $78.74 M(+89.1%) |
| Jun 2018 | - | $41.65 M(-15.5%) |
| Mar 2018 | - | $49.27 M(-16.4%) |
| Dec 2017 | $58.91 M(+458.3%) | $58.91 M(-13.6%) |
| Sep 2017 | - | $68.18 M(+314.0%) |
| Jun 2017 | - | $16.47 M(+44.0%) |
| Mar 2017 | - | $11.44 M(+8.4%) |
| Dec 2016 | $10.55 M(+10.0%) | $10.55 M(-30.4%) |
| Sep 2016 | - | $15.15 M(+22.2%) |
| Jun 2016 | - | $12.40 M(+10.6%) |
| Mar 2016 | - | $11.21 M(+16.9%) |
| Dec 2015 | $9.59 M(+14.3%) | $9.59 M(-30.1%) |
| Sep 2015 | - | $13.71 M(+29.7%) |
| Jun 2015 | - | $10.57 M(-49.8%) |
| Mar 2015 | - | $21.06 M(+151.0%) |
| Dec 2014 | $8.39 M | $8.39 M(-25.3%) |
| Sep 2014 | - | $11.24 M(+73.9%) |
| Jun 2014 | - | $6.46 M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $6.74 M(-7.4%) |
| Dec 2013 | $7.28 M(-34.0%) | $7.28 M(+81.9%) |
| Sep 2013 | - | $4.00 M(-9.3%) |
| Jun 2013 | - | $4.41 M(-78.3%) |
| Mar 2013 | - | $20.36 M(+84.6%) |
| Dec 2012 | $11.03 M(+87.5%) | $11.03 M(+27.7%) |
| Sep 2012 | - | $8.63 M(+3.9%) |
| Jun 2012 | - | $8.31 M(-68.0%) |
| Mar 2012 | - | $25.93 M(+340.9%) |
| Dec 2011 | $5.88 M(-32.3%) | $5.88 M(-3.2%) |
| Sep 2011 | - | $6.08 M(-42.7%) |
| Jun 2011 | - | $10.60 M(-64.6%) |
| Mar 2011 | - | $29.92 M(+244.3%) |
| Dec 2010 | $8.69 M(-2.7%) | $8.69 M(+120.6%) |
| Sep 2010 | - | $3.94 M(+5.6%) |
| Jun 2010 | - | $3.73 M(-44.3%) |
| Mar 2010 | - | $6.70 M(-25.0%) |
| Dec 2009 | $8.93 M(-42.2%) | $8.93 M(+112.5%) |
| Sep 2009 | - | $4.21 M(-20.3%) |
| Jun 2009 | - | $5.28 M(-57.2%) |
| Mar 2009 | - | $12.34 M(-20.2%) |
| Dec 2008 | $15.47 M(+35.6%) | $15.47 M(-32.6%) |
| Sep 2008 | - | $22.95 M(+108.6%) |
| Jun 2008 | - | $11.00 M(-14.9%) |
| Mar 2008 | - | $12.93 M(+13.4%) |
| Dec 2007 | $11.40 M(-59.9%) | $11.40 M(-28.3%) |
| Sep 2007 | - | $15.91 M(-3.2%) |
| Jun 2007 | - | $16.44 M(-23.2%) |
| Mar 2007 | - | $21.40 M(-24.8%) |
| Dec 2006 | $28.45 M(-62.0%) | $28.45 M(-25.9%) |
| Sep 2006 | - | $38.40 M(-16.6%) |
| Jun 2006 | - | $46.06 M(-14.5%) |
| Mar 2006 | - | $53.89 M(-28.1%) |
| Dec 2005 | $74.95 M(+422.7%) | $74.95 M(+125.2%) |
| Sep 2005 | - | $33.27 M(-16.6%) |
| Jun 2005 | - | $39.91 M(-11.3%) |
| Mar 2005 | - | $44.98 M(+213.7%) |
| Dec 2004 | $14.34 M(-64.7%) | $14.34 M(-11.7%) |
| Sep 2004 | - | $16.24 M |
| Dec 2003 | $40.61 M(+553.4%) | - |
| Dec 2002 | $6.21 M | - |
FAQ
- What is Molecular Templates annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Molecular Templates?
- What is Molecular Templates annual cash & cash equivalents year-on-year change?
- What is Molecular Templates quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Molecular Templates?
- What is Molecular Templates quarterly cash and cash equivalents year-on-year change?
What is Molecular Templates annual cash & cash equivalents?
The current annual cash & cash equivalents of MTEM is $11.52 M
What is the all time high annual cash & cash equivalents for Molecular Templates?
Molecular Templates all-time high annual cash & cash equivalents is $87.72 M
What is Molecular Templates annual cash & cash equivalents year-on-year change?
Over the past year, MTEM annual cash & cash equivalents has changed by -$20.67 M (-64.20%)
What is Molecular Templates quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MTEM is $9.66 M
What is the all time high quarterly cash and cash equivalents for Molecular Templates?
Molecular Templates all-time high quarterly cash and cash equivalents is $98.79 M
What is Molecular Templates quarterly cash and cash equivalents year-on-year change?
Over the past year, MTEM quarterly cash and cash equivalents has changed by +$2.88 M (+42.45%)